Selected research
Market Structure
Global Artificial Intelligence in Medical Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Artificial Intelligence in Medical Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Artificial Intelligence in Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Artificial Intelligence in Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artificial Intelligence in Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Artificial Intelligence in Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Artificial Intelligence in Medical Software include 2bPrecise, CliniSys, Fabric Genomics, Flatiron Health, Foundation Medicine, Gene42, Human Longevity, IBM and Koninklijke Philips, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Artificial Intelligence in Medical Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artificial Intelligence in Medical Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artificial Intelligence in Medical Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Artificial Intelligence in Medical Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Artificial Intelligence in Medical Software Segment by Company
2bPrecise
CliniSys
Fabric Genomics
Flatiron Health
Foundation Medicine
Gene42
Human Longevity
IBM
Koninklijke Philips
LifeOmic Health
Pierian
SOPHiA GENETICS
Syapse
Tempus
Translational Software
Artificial Intelligence in Medical Software Segment by Type
Image Recognition
Natural Language Processing
Others
Artificial Intelligence in Medical Software Segment by Application
Drug Discovery
Precision Medicine
Others
Artificial Intelligence in Medical Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Medical Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Medical Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Medical Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Artificial Intelligence in Medical Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence in Medical Software industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Medical Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Medical Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Image Recognition
- Natural Language Processing
- Others
Applications
- Drug Discovery
- Precision Medicine
- Others
Companies covered
- 2bPrecise
- CliniSys
- Fabric Genomics
- Flatiron Health
- Foundation Medicine
- Gene42
- Human Longevity
- IBM
- Koninklijke Philips
- LifeOmic Health
- Pierian
- SOPHiA GENETICS
- Syapse
- Tempus
- Translational Software
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Artificial Intelligence in Medical Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Image Recognition
- 1.2.3 Natural Language Processing
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Artificial Intelligence in Medical Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drug Discovery
- 1.3.3 Precision Medicine
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Artificial Intelligence in Medical Software Growth Trends by Region
- 1.5.1 Global Artificial Intelligence in Medical Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Artificial Intelligence in Medical Software Market Size by Region (2021-2026)
- 1.5.3 Artificial Intelligence in Medical Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Artificial Intelligence in Medical Software Market Dynamics
- 2.1 Artificial Intelligence in Medical Software Industry Trends
- 2.2 Artificial Intelligence in Medical Software Industry Drivers
- 2.3 Artificial Intelligence in Medical Software Industry Opportunities and Challenges
- 2.4 Artificial Intelligence in Medical Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Artificial Intelligence in Medical Software Revenue by Company (2021-2026)
- 3.2 Global Artificial Intelligence in Medical Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Artificial Intelligence in Medical Software Key Company Head office and Area Served
- 3.4 Global Artificial Intelligence in Medical Software Company, Product Type & Application
- 3.5 Global Artificial Intelligence in Medical Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Artificial Intelligence in Medical Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Artificial Intelligence in Medical Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Artificial Intelligence in Medical Software Tier 1, Tier 2, and Tier 3
4 Artificial Intelligence in Medical Software Market by Type
- 4.1 Global Artificial Intelligence in Medical Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Artificial Intelligence in Medical Software Market Size by Type (2021-2032)
- 4.3 Global Artificial Intelligence in Medical Software Market Size Share by Type (2021-2032)
5 Artificial Intelligence in Medical Software Market by Application
- 5.1 Global Artificial Intelligence in Medical Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Artificial Intelligence in Medical Software Market Size by Application (2021-2032)
- 5.3 Global Artificial Intelligence in Medical Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 2bPrecise
- 6.1.1 2bPrecise Company Information
- 6.1.2 2bPrecise Business Overview
- 6.1.3 2bPrecise Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 2bPrecise Artificial Intelligence in Medical Software Product Portfolio
- 6.1.5 2bPrecise Recent Developments
- 6.2 CliniSys
- 6.2.1 CliniSys Company Information
- 6.2.2 CliniSys Business Overview
- 6.2.3 CliniSys Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 CliniSys Artificial Intelligence in Medical Software Product Portfolio
- 6.2.5 CliniSys Recent Developments
- 6.3 Fabric Genomics
- 6.3.1 Fabric Genomics Company Information
- 6.3.2 Fabric Genomics Business Overview
- 6.3.3 Fabric Genomics Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Fabric Genomics Artificial Intelligence in Medical Software Product Portfolio
- 6.3.5 Fabric Genomics Recent Developments
- 6.4 Flatiron Health
- 6.4.1 Flatiron Health Company Information
- 6.4.2 Flatiron Health Business Overview
- 6.4.3 Flatiron Health Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Flatiron Health Artificial Intelligence in Medical Software Product Portfolio
- 6.4.5 Flatiron Health Recent Developments
- 6.5 Foundation Medicine
- 6.5.1 Foundation Medicine Company Information
- 6.5.2 Foundation Medicine Business Overview
- 6.5.3 Foundation Medicine Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Foundation Medicine Artificial Intelligence in Medical Software Product Portfolio
- 6.5.5 Foundation Medicine Recent Developments
- 6.6 Gene42
- 6.6.1 Gene42 Company Information
- 6.6.2 Gene42 Business Overview
- 6.6.3 Gene42 Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Gene42 Artificial Intelligence in Medical Software Product Portfolio
- 6.6.5 Gene42 Recent Developments
- 6.7 Human Longevity
- 6.7.1 Human Longevity Company Information
- 6.7.2 Human Longevity Business Overview
- 6.7.3 Human Longevity Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Human Longevity Artificial Intelligence in Medical Software Product Portfolio
- 6.7.5 Human Longevity Recent Developments
- 6.8 IBM
- 6.8.1 IBM Company Information
- 6.8.2 IBM Business Overview
- 6.8.3 IBM Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 IBM Artificial Intelligence in Medical Software Product Portfolio
- 6.8.5 IBM Recent Developments
- 6.9 Koninklijke Philips
- 6.9.1 Koninklijke Philips Company Information
- 6.9.2 Koninklijke Philips Business Overview
- 6.9.3 Koninklijke Philips Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Koninklijke Philips Artificial Intelligence in Medical Software Product Portfolio
- 6.9.5 Koninklijke Philips Recent Developments
- 6.10 LifeOmic Health
- 6.10.1 LifeOmic Health Company Information
- 6.10.2 LifeOmic Health Business Overview
- 6.10.3 LifeOmic Health Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 LifeOmic Health Artificial Intelligence in Medical Software Product Portfolio
- 6.10.5 LifeOmic Health Recent Developments
- 6.11 Pierian
- 6.11.1 Pierian Company Information
- 6.11.2 Pierian Business Overview
- 6.11.3 Pierian Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Pierian Artificial Intelligence in Medical Software Product Portfolio
- 6.11.5 Pierian Recent Developments
- 6.12 SOPHiA GENETICS
- 6.12.1 SOPHiA GENETICS Company Information
- 6.12.2 SOPHiA GENETICS Business Overview
- 6.12.3 SOPHiA GENETICS Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 SOPHiA GENETICS Artificial Intelligence in Medical Software Product Portfolio
- 6.12.5 SOPHiA GENETICS Recent Developments
- 6.13 Syapse
- 6.13.1 Syapse Company Information
- 6.13.2 Syapse Business Overview
- 6.13.3 Syapse Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Syapse Artificial Intelligence in Medical Software Product Portfolio
- 6.13.5 Syapse Recent Developments
- 6.14 Tempus
- 6.14.1 Tempus Company Information
- 6.14.2 Tempus Business Overview
- 6.14.3 Tempus Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Tempus Artificial Intelligence in Medical Software Product Portfolio
- 6.14.5 Tempus Recent Developments
- 6.15 Translational Software
- 6.15.1 Translational Software Company Information
- 6.15.2 Translational Software Business Overview
- 6.15.3 Translational Software Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Translational Software Artificial Intelligence in Medical Software Product Portfolio
- 6.15.5 Translational Software Recent Developments
7 North America
- 7.1 North America Artificial Intelligence in Medical Software Market Size (2021-2032)
- 7.2 North America Artificial Intelligence in Medical Software Market Size by Type
- 7.2.1 North America Artificial Intelligence in Medical Software Market Size by Type (2021-2026)
- 7.2.2 North America Artificial Intelligence in Medical Software Market Size by Type (2027-2032)
- 7.2.3 North America Artificial Intelligence in Medical Software Market Share by Type (2021-2032)
- 7.3 North America Artificial Intelligence in Medical Software Market Size by Application
- 7.3.1 North America Artificial Intelligence in Medical Software Market Size by Application (2021-2026)
- 7.3.2 North America Artificial Intelligence in Medical Software Market Size by Application (2027-2032)
- 7.3.3 North America Artificial Intelligence in Medical Software Market Share by Application (2021-2032)
- 7.4 North America Artificial Intelligence in Medical Software Market Size by Country
- 7.4.1 North America Artificial Intelligence in Medical Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Artificial Intelligence in Medical Software Market Size by Country (2021-2026)
- 7.4.3 North America Artificial Intelligence in Medical Software Market Size by Country (2027-2032)
- 7.4.4 North America Artificial Intelligence in Medical Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Artificial Intelligence in Medical Software Market Size (2021-2032)
- 8.2 Europe Artificial Intelligence in Medical Software Market Size by Type
- 8.2.1 Europe Artificial Intelligence in Medical Software Market Size by Type (2021-2026)
- 8.2.2 Europe Artificial Intelligence in Medical Software Market Size by Type (2027-2032)
- 8.2.3 Europe Artificial Intelligence in Medical Software Market Share by Type (2021-2032)
- 8.3 Europe Artificial Intelligence in Medical Software Market Size by Application
- 8.3.1 Europe Artificial Intelligence in Medical Software Market Size by Application (2021-2026)
- 8.3.2 Europe Artificial Intelligence in Medical Software Market Size by Application (2027-2032)
- 8.3.3 Europe Artificial Intelligence in Medical Software Market Share by Application (2021-2032)
- 8.4 Europe Artificial Intelligence in Medical Software Market Size by Country
- 8.4.1 Europe Artificial Intelligence in Medical Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Artificial Intelligence in Medical Software Market Size by Country (2021-2026)
- 8.4.3 Europe Artificial Intelligence in Medical Software Market Size by Country (2027-2032)
- 8.4.4 Europe Artificial Intelligence in Medical Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Artificial Intelligence in Medical Software Market Size (2021-2032)
- 9.2 China Artificial Intelligence in Medical Software Market Size by Type
- 9.2.1 China Artificial Intelligence in Medical Software Market Size by Type (2021-2026)
- 9.2.2 China Artificial Intelligence in Medical Software Market Size by Type (2027-2032)
- 9.2.3 China Artificial Intelligence in Medical Software Market Share by Type (2021-2032)
- 9.3 China Artificial Intelligence in Medical Software Market Size by Application
- 9.3.1 China Artificial Intelligence in Medical Software Market Size by Application (2021-2026)
- 9.3.2 China Artificial Intelligence in Medical Software Market Size by Application (2027-2032)
- 9.3.3 China Artificial Intelligence in Medical Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Artificial Intelligence in Medical Software Market Size (2021-2032)
- 10.2 Asia Artificial Intelligence in Medical Software Market Size by Type
- 10.2.1 Asia Artificial Intelligence in Medical Software Market Size by Type (2021-2026)
- 10.2.2 Asia Artificial Intelligence in Medical Software Market Size by Type (2027-2032)
- 10.2.3 Asia Artificial Intelligence in Medical Software Market Share by Type (2021-2032)
- 10.3 Asia Artificial Intelligence in Medical Software Market Size by Application
- 10.3.1 Asia Artificial Intelligence in Medical Software Market Size by Application (2021-2026)
- 10.3.2 Asia Artificial Intelligence in Medical Software Market Size by Application (2027-2032)
- 10.3.3 Asia Artificial Intelligence in Medical Software Market Share by Application (2021-2032)
- 10.4 Asia Artificial Intelligence in Medical Software Market Size by Country
- 10.4.1 Asia Artificial Intelligence in Medical Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Artificial Intelligence in Medical Software Market Size by Country (2021-2026)
- 10.4.3 Asia Artificial Intelligence in Medical Software Market Size by Country (2027-2032)
- 10.4.4 Asia Artificial Intelligence in Medical Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Artificial Intelligence in Medical Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst